| TTM
|
12/31/2025
|
12/31/2024
|
12/31/2023
|
12/31/2022
|
|
|---|---|---|---|---|---|
| Total Revenue
|
80,415 | 57,873 | 51,320 | 35,522 | 46,825 |
| Cost of Revenue
|
-37,459 | -23,995 | -18,449 | -9,950 | -15,954 |
|
Gross Profit
|
42,956 | 33,878 | 32,871 | 25,572 | 30,871 |
| Selling, General and Administrative Expenses
|
-45,981 | -41,653 | -43,797 | -38,953 | -39,851 |
|
Research and Development Expenses
|
-40,434 | -16,019 | -20,630 | -36,225 | -45,077 |
| Other Income/Expense, Operating
|
3,508 | 5,188 | 2,699 | 2,754 | 4,552 |
|
Operating Income/Expenses
|
-82,907 | -52,484 | -61,728 | -72,424 | -80,376 |
|
Total Operating Profit/Loss
|
-39,951 | -18,606 | -28,857 | -46,852 | -49,505 |
| Total Net Finance Income/Expense
|
2,845 | 1,069 | -2,831 | 300 | 98 |
| Net Investment Income
|
-2,612 | -2,612 | 180 | 45 | 2,203 |
| Irregular Income/Expenses
|
-- | -- | -- | 0 | 50 |
|
Non-Operating Income/Expenses, Total
|
2,845 | -1,543 | -2,651 | 345 | 2,351 |
|
Pretax Income
|
-37,106 | -20,149 | -31,508 | -46,507 | -47,154 |
| Provision for Income Tax
|
0 | 0 | 29 | 3 | 0 |
|
Net Income from Continuing Operations
|
-37,106 | -20,149 | -31,479 | -46,504 | -47,154 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
-37,106 | -20,149 | -31,479 | -46,504 | -47,154 |
|
Net Income after Non-Controlling/Minority Interests
|
-37,106 | -20,149 | -31,479 | -46,504 | -47,154 |
|
Net Income Available to Common Stockholders
|
-37,106 | -20,149 | -31,479 | -46,504 | -47,154 |
|
Diluted Net Income Available to Common Stockholders
|
-37,106 | -20,149 | -31,479 | -46,504 | -47,154 |
| Basic EPS
|
-0.50 | -0.29 | -0.59 | -1.29 | -1.32 |
| Diluted EPS
|
-0.50 | -0.29 | -0.59 | -1.29 | -1.32 |
|
Basic Weighted Average Shares Outstanding
|
75,724.23 | 71,498.27 | 53,769.89 | 36,229.87 | 35,594.75 |
|
Diluted Weighted Average Shares Outstanding
|
75,922.97 | 71,912.76 | 55,365.13 | 38,054.35 | 36,948.94 |
| Income Statement, Supplemental
|
|||||
|
EBIT
|
-39,951 | -21,218 | -28,677 | -46,807 | -47,252 |
|
EBITDA
|
-39,951 | -17,730 | -25,976 | -37,451 | -36,297 |
|
Normalized EBITDA
|
-39,951 | -17,730 | -25,976 | -37,451 | -36,343 |
|
Normalized Income
|
-37,106 | -20,149 | -31,479 | -46,504 | -47,200 |
|
Total Unusual Items
|
0 | 0 | 0 | 0 | -46 |
|
Total Unusual Items Excluding Goodwill
|
0 | 0 | 0 | 0 | -46 |
12/31/2022 - 12/11/2017
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade